Home › Funds › PSP Research LLC › HALO

PSP Research LLC position in HALO

HALOZYME THERAPEUTICS INC · Health Care

PSP Research LLC reported holding 3,000 shares of HALO (HALOZYME THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$331K, representing 0.23% of its reported portfolio and ranking #4 among its reported holdings. PSP Research LLC has disclosed HALO holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)3.00K sh
Reported value held$331.20K
Portfolio Weight0.23%
First reportedQ4 2025
Last changeReduce
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How PSP Research LLC's HALO position evolved

PSP Research LLC first disclosed a stake in HALO in Q4 2025 at 8,026 shares (US$540K). The position peaked in Q2 2026 at 7,000 shares, worth US$548K. Across 4 filings, PSP Research LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 3,000 shares valued at US$331K — a reduction of -4,000 shares quarter over quarter.. Notable position changes include a 57% trim in Q3 2026 (shares rose 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 8.03K $540.15K New
Q1 2026 8.03K $518.72K Hold
Q2 2026 7.00K $547.89K Reduce
Q3 2026 3.00K $331.20K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HALO and 13F data

HALO (HALOZYME THERAPEUTICS INC) is a Health Care company. 43 other funds we track also report a position in HALO — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$251.9M), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (US$196.5M), SNYDER CAPITAL MANAGEMENT L P (US$187.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HALO

All HALO fund holders →

FAQ

How long has PSP Research LLC held HALO?

PSP Research LLC has disclosed HALO holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is PSP Research LLC's current position in HALO?

As of Q3 2026, PSP Research LLC holds 3.00K shares of HALO (HALOZYME THERAPEUTICS INC), valued at $331.20K, representing 0.23% of its reported portfolio and ranking #4.

Has PSP Research LLC been buying or selling HALO?

In the latest 13F filing (Q3 2026), PSP Research LLC reduced its position in HALO. The position peaked in Q2 2026 at 7.00K shares.

Which other funds hold HALO?

Other major institutional holders of HALO include CONGRESS ASSET MANAGEMENT CO, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, SNYDER CAPITAL MANAGEMENT L P, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.